-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$95.0063.74% Upside
Apogee Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus in the past 90 days.